Who owns PYXIS ONCOLOGY INC?
- Ticker: PYXS
- CUSIP Number: 747324101
Tip: Access positions for across all investors
Analyze quarterly positions in Pyxis Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pyxis Oncology stock
Who bought or sold PYXIS ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pfizer | 7.0M | $16M | 0% | Sep 2025 |
|
| Laurion Capital Management | 3.6M | $8.0M | 0% | Sep 2025 |
|
| Tang Capital Management | 2.5M | $5.6M | 0% | Sep 2025 |
|
| Vanguard Group | 2.2M | $4.8M | 1% | Sep 2025 |
|
| Perceptive Advisors | 1.2M | $2.6M | 100% | Sep 2025 |
|
| Palo Alto Investors | 1.0M | $2.3M | 0% | Sep 2025 |
|
| Millennium Management | 815k | $1.8M | -77% | Sep 2025 |
|
| Stempoint Capital | 690k | $1.5M | 100% | Sep 2025 |
|
| BlackRock | 684k | $1.5M | -26% | Sep 2025 |
|
| Renaissance Technologies | 576k | $1.3M | 38% | Sep 2025 |
|
| Geode Capital Management | 545k | $1.2M | 7% | Sep 2025 |
|
| 683 Capital Management | 525k | $1.2M | -4% | Sep 2025 |
|
| Driehaus Capital Management | 419k | $929k | 100% | Sep 2025 |
|
| UBS Group | 374k | $830k | -6% | Sep 2025 |
|
| Citadel Advisors | 337k | $749k | 100% | Sep 2025 |
|
| Decheng Capital | 327k | $726k | 0% | Sep 2025 |
|
| Jane Street | 304k | $674k | -10% | Sep 2025 |
|
| Schulhoff & Company | 275k | $611k | 0% | Sep 2025 |
|
| State Street Corporation | 202k | $449k | 9% | Sep 2025 |
|
| Bank of New York Mellon | 165k | $366k | 0% | Sep 2025 |
|
| Morgan Stanley | 160k | $176k | 100% | Jun 2025 |
|
| Susquehanna International | 159k | $353k | 39% | Sep 2025 |
|
| Pier 88 Investment Partners | 152k | $337k | -59% | Sep 2025 |
|
| Diadema Partners | 150k | $333k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 126k | $279k | -22% | Sep 2025 |
|
| Walleye Trading Advisors | 120k | $265k | 100% | Sep 2025 |
|
| NewEdge Wealth | 116k | $454k | 0% | Sep 2025 |
|
| Northern Trust | 101k | $224k | -1% | Sep 2025 |
|
| Royal Bank of Canada | 78k | $0 | -10% | Sep 2025 |
|
| Bridgeway Capital Management | 77k | $170k | -46% | Sep 2025 |
|
| Cable Car Capital | 62k | $137k | 0% | Sep 2025 |
|
| Commonwealth Equity Services | 61k | $136k | 0% | Sep 2025 |
|
| Jacobs Levy Equity Management | 60k | $134k | 100% | Sep 2025 |
|
| Velan Capital Investment Management | 55k | $122k | 38% | Sep 2025 |
|
| Two Sigma Advisers | 53k | $117k | 100% | Sep 2025 |
|
| University Of Chicago | 49k | $108k | 0% | Sep 2025 |
|
| Two Sigma Investments | 47k | $103k | 100% | Sep 2025 |
|
| Acadian Asset Management | 43k | $94k | 127% | Sep 2025 |
|
| Dimensional Fund Advisors | 37k | $81k | 0% | Sep 2025 |
|
| Cubist Systematic Strategies | 33k | $73k | 100% | Sep 2025 |
|
| Qube Research & Technologies | 31k | $68k | -70% | Sep 2025 |
|
| Cetera Investment Advisers | 28k | $62k | -3% | Sep 2025 |
|
| Point72 Asia | 18k | $40k | -6% | Sep 2025 |
|
| XTX Topco | 18k | $39k | -51% | Sep 2025 |
|
| Prudential Financial | 16k | $36k | 100% | Sep 2025 |
|
| FMR | 16k | $34k | -84% | Sep 2025 |
|
| Hrt Financial | 15k | $34k | -70% | Sep 2025 |
|
| Advisor Group Holdings | 15k | $20k | -14% | Sep 2025 |
|
| LPL Financial | 14k | $31k | -1% | Sep 2025 |
|
| AQR Capital Management | 14k | $28k | -84% | Sep 2025 |
|
| Tower Research Capital | 13k | $29k | -11% | Sep 2025 |
|
| China Universal Asset Management | 11k | $24k | -13% | Sep 2025 |
|
| Simplex Trading | 7.4k | $16k | -41% | Sep 2025 |
|
| Winthrop Capital Management | 6.0k | $13k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 4.5k | $10k | -84% | Sep 2025 |
|
| Barclays | 3.0k | $6.6k | -39% | Sep 2025 |
|
| Mirae Asset Global Investments | 2.4k | $5.3k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.7k | $3.8k | -6% | Sep 2025 |
|
| Gf Fund Management | 1.3k | $3.0k | -7% | Sep 2025 |
|
| NISA Investment Advisors | 961.00 | $2.1k | 0% | Sep 2025 |
|
| UMA Financial Services | 943.00 | $2.1k | 0% | Sep 2025 |
|
| Jones Financial Companies, L.L | 500.00 | $1.1k | -67% | Sep 2025 |
|
| EverSource Wealth Advisors | 434.00 | $991.993800 | -27% | Sep 2025 |
|
| CWM | 414.00 | $1.0k | -94% | Sep 2025 |
|
| Wells Fargo & Company | 285.00 | $633.013500 | -59% | Sep 2025 |
|
| Goss Wealth Management | 250.00 | $555.000000 | 0% | Sep 2025 |
|
| SRS Capital Advisors | 14.00 | $31.000200 | 100% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 12.00 | $27.000000 | 0% | Sep 2025 |
|
| SBI Securities | 2.00 | $4.000000 | 100% | Sep 2025 |
|
Who sold out of Pyxis Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Standard Life Aberdeen | Jun 2025 | 913k | $1.0M |
| Marshall Wace | Jun 2025 | 148k | $163k |
| Y-Intercept | Jun 2025 | 133k | $146k |
| Jain Global | Jun 2025 | 49k | $54k |
| Squarepoint Ops | Jun 2025 | 35k | $39k |
| Catalyst Funds Management Pty | Jun 2025 | 23k | $26k |
| Hudson Bay Capital Management | Jun 2025 | 14k | $15k |
| DRW Holdings | Jun 2025 | 13k | $14k |
| Cibc World Markets | Mar 2025 | 11k | $11k |
| Mercer Global Advisors | Jun 2025 | 10k | $11k |
| Raymond James Financial | Jun 2025 | 3.2k | $3.6k |
| Group One Trading | Jun 2025 | 602.00 | $662.019400 |
| True Wealth Design | Jun 2025 | 276.00 | $303.986400 |
| Russell Investments | Jun 2025 | 64.00 | $70.003200 |